Interim Dean Rachel Rebouché says the FDA should state its intent for federal preemption to curb state regulation of mifepristone, one of the drugs used in medication abortion. Read more.
Published on June 9, 2022
FDA Abortion Pill Policy May Preempt State Restrictions, Say Legal Scholars: ‘We Need to Push the Boundaries and See What Sticks’
